[[Michael M. Gottesman]]

CATEGORIES: 1946 births, Living people, Harvard Medical School alumni, American biochemists, Fellows of the American Association for the Advancement of Science

Michael M. Gottesman (born  October 7, 1946 in Jersey City, New JerseyBiography as a speaker at the 1999 Conference on Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics, Office of Research on Women's Health, retrieved 2010-02-28.) is an American biochemist, the Deputy Director (Intramural) of the National Institutes of Health (NIH) in the United States, and also Chief of the Laboratory of Cell Biology at the National Cancer Institute (NCI) within the NIH.Staff profile, NCI, retrieved 2010-02-28. He graduated summa cum laude in biochemical sciences in 1966 from Harvard College, and received his M.D. magna cum laude from Harvard Medical School in 1970. He then worked as an intern and resident at the Peter Dent Brigham Hospital in Boston, a research associate at the NIH, and an assistant professor at Harvard before taking a permanent position at the NIH in 1976.
His areas of expertise includes a major contribution to the discovery of P-glycoprotein (MDR1, ABCB1), the multidrug resistance efflux transporter associated with clinical resistance to anti-cancer agents.[ref]
.</ref><ref>
